Mukka Proteins Q4 FY26: Growth in scale, margins under pressure, and a bigger ESG platform

For FY26, total revenue from operations was INR 1,449.5 crore, EBITDA was INR 145.3 crore (10.0% margin), and PAT was INR 57.1 crore (3.9% margin), as per the presentation.

For Q4 FY26, revenue from operations was INR 380.6 crore and PAT was INR 21.4 crore (5.6% margin) as shown in the Q4 performance section. EBITDA is shown as 49.2 crore on the chart with a 12.9% margin in the same slide.

The presentation states export revenue share of 79.7% in FY26, with presence across 25 plus countries.

The order value is stated as INR 474.89 crore (ex-GST) with estimated capex of about INR 100 crore, about 6 months build, and a 4-year project duration. JV stake is stated as 76%.

The presentation lists four core verticals: Fish Protein, Alternate Proteins (insect biotech), Waste Management (leachate management), and Frozen and Value Added marine products.

The alternate proteins slide states capacities of 200 TPD in Mangaluru, 1,000 TPD in Bengaluru, and 200 TPD in Kochi for the BSF-based platform.

The presentation shows a revenue growth outlook of INR 3,000 crore plus by FY30, compared with INR 1,449 crore for FY26, indicating more than 2x growth targeted in about 4 years.